BCCs strongly expressed GPR4 in only 16.6% of the cases, while the other 83.3% of BCC showed no expression (Figs. 4a,e,i, 5b and Supplementary Figs. S3–S17 first column). This evidence concerns the gene GPR4 and skin basal cell carcinoma.